News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Research Dynamics Consulting Group, Ltd. Becomes DATATRAK International, Inc. (DATA) Connect Partner



6/14/2011 7:44:56 AM

CLEVELAND, June 14, 2011 /PRNewswire/ -- DATATRAK International, Inc. (OTCQX: DATA), a technology and services company focused on global eClinical solutions for the clinical trials industry, today announced the addition of Research Dynamics Consulting Group LTD to its Connect Partner Program. The DATATRAK software suite complements the CRO's Clinical Services focus and its innovative processes using state-of-the-art clinical trial technology.

"We look forward to integrating DATATRAK technologies into our clinical trial processes to gain additional efficiencies," noted Lorraine D. Ellis, Research Dynamics' President and CEO. "In addition, working with DATATRAK's Clinical and Consulting Services (DCCS) will allow us to broaden our services. These new capabilities will result in more efficient, cost-effective, and speedier trials for our customers."

"Lorraine Ellis and her national certification as a Woman-Owned Business bring a unique perspective to DATATRAK's Connect Partner Program by not only extending our DATATRAK ONE technologies but also dovetailing with our DCCS service offering," stated Laurence P. Birch, DATATRAK's Chairman of the Board and CEO. "Our unified technology coupled with Research Dynamics' service offerings will open new doors for both of our companies. We are eager to support Lorraine and her team as this new relationship develops."

About Research Dynamics

Founded in 1993, Research Dynamics is a CRO (Contract Research Organization) specializing in the management of clinical research trials for the biopharmaceutical and medical device industries. Our services include project management, monitoring, site selection and management, EDC, and associated clinical operations and data services. Although we work in all therapeutic areas, our expertise and focus are in the following areas: allergy, dermatology, infectious diseases, critical care, HIV and hepatitis, respiratory, ophthalmology, wound healing, in-vitro diagnostics, and various medical devices. Research Dynamics is also known for its clinical research training programs and training resources. Research Dynamics provides the expertise and experience of large CROs with the flexibility and customization of a smaller organization. For more information visit our website, www.resdyncg.com.

About DATATRAK International, Inc.

DATATRAK International is a worldwide technology and services company delivering eClinical solutions and related services for the clinical trials industry. DATATRAK built its multi-component, comprehensive solution on a single, unified platform and expanded this concept to include services delivery via DATATRAK's Clinical and Consulting Services group. The Company delivers a complete portfolio of software products designed to accelerate the reporting of clinical research data from sites to sponsors and ultimately regulatory authorities, faster and more efficiently than loosely integrated technologies. The DATATRAK eClinical® software solution, deployed worldwide through an ASP or Enterprise Transfer offering, supports Phase I - Phase IV drug and devices studies in multiple languages throughout the world. DATATRAK has offices located in Cleveland, Ohio; Bryan, Texas; and Cary (RTP), North Carolina. For more information, visit http://www.datatrak.net.

Except for the historical information contained in this press release, the statements made in this release are forward-looking statements. These forward-looking statements are made based on management's expectations, assumptions, estimates and current beliefs concerning the operations, future results and prospects of the Company and are subject to uncertainties and factors which are difficult to predict and, in many instances, are beyond the control of the Company, and which could cause actual results to differ materially from those contemplated in these forward-looking statements. For a list of certain of the factors that may cause actual results to differ materially from those contemplated in these forward looking statements, please see the Company's quarterly report filed with the OTCQX Market announcing its results for the three-month period ending March 31, 2011. The Company undertakes no obligation to update publicly or revise any forward-looking statement whether as a result of new information, future events or otherwise.

SOURCE DATATRAK International, Inc.


Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES